AzTrials
AzTrials

Cesarean DeliveryDEMEMNCT06809985

Latent Phase Membrane Stripping for Caesarean Section Reduction

A study testing Hamilton maneuver in people with Cesarean Delivery and Cervical Ripening, run by Ricardo A Gutierrez Ramirez, MD, MSc, FACOG at 1 site in Honduras.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In the Hospital Escuela, the availability of beds and criteria for admission to the intensive care unit ICU are not the same, the use of this marker is questionable, as it is affected by the level of complexity of care provided to a health setting and the organization of obstetric care. Read more about this study

Who is it for?
Ages 18 to 45 years, women onlyHealthy volunteers can take part
What is being tested?
Hamilton maneuver
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
71 participants
Where
1 siteHonduras
Study dates
31 Jan 2025to 1 Sep 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Submission of a signed and dated informed consent form.
  • Declared willingness to comply with all study procedures and availability for the duration of the study.
  • nulliparous
  • woman with singleton pregnancy at 37 weeks or more
  • integral membranes
  • cephalic presentation
  • Bishop's score less than 7
  • No contraindication for vaginal delivery

Who cannot join

  • Previous uterine surgery
  • Maternal condition preventing vaginal delivery
  • Fetal anomaly
  • Premature rupture of membranes
  • Multiple pregnancy
  • Fetal orbit
Show all 9Show fewer
  • Myomas
  • Maternal comorbidities such as chronic arterial hypertension, type 1, 2 and gestational diabetes, hypothyroidism, among others.
  • Anemia

Trial locations and contacts

1 site in 1 country.

Honduras1 site
  • Hospital Escuela

    Tegucigalpa, Francisco Morazán Department, 11101

Other trials in Honduras

About this study

Official title: Latent Phase Membrane Stripping for Caesarean Section Reduction. Single Blind Clinical Trial

In the Hospital Escuela, the availability of beds and criteria for admission to the intensive care unit ICU are not the same, the use of this marker is questionable, as it is affected by the level of complexity of care provided to a health setting and the organization of obstetric care. The cesarean section rate (almost 63.2%), is without significant variation by different criteria.

The importance of finding strategies to reduce the rate of cesarean births and thus counteract the high rates of maternal morbidity and mortality is proposed. For this reason, this research is aimed at reducing the latent phase of labor through the use of the Hamilton maneuver.

Read the detailed description

There is a need to find non-pharmacological interventions that can speed up delivery to prevent maternal complications and reduce the number of caesarean sections.

Maternal mortality remains one of the biggest health problems worldwide. Every day, around 830 women die worldwide from complications related to pregnancy or childbirth. In 2015, an estimated 303,000 women died during pregnancy and childbirth or after. Most of these deaths occur in low-income countries and most of them could have been prevented. The maternal mortality rate in Latin American and Caribbean countries, calculated by the Inter-Agency Group (MMEIG), shows a significant decrease as a regional average in recent years, from 88 per 100,000 live births in 2005 to 67 per 100,000 live births in 2015.

At the Escuela Hospital, the availability of beds and admission criteria in the intensive care unit (ICU) are not the same. The use of this marker is questionable, since it is affected by the level of complexity of the care provided to a health setting and the organization of obstetric care. We found in our study a cesarean section rate (almost 63.2%), with no significant variation by different criteria. This finding is consistent with that reported by Nelissen et al. Due to the severity of the obstetric conditions of these patients, their pregnancy usually requires urgent action. Although cesarean section is associated with high rates of maternal morbidity and mortality compared to vaginal delivery, when clinically indicated, timely termination of pregnancy can reduce the risk of maternal-fetal death.

Based on the above, this research proposes the importance of finding strategies to reduce the rate of cesarean deliveries and thus counteract the high rates of maternal morbidity and mortality. For this reason, this research is aimed at reducing the latent phase of labor through the use of the Hamilton maneuver.

Being tested
Hamilton maneuver
Keywords
Cesarean Delivery, Cervical ripening, latent phase labour, hamilton maneuver

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Hamilton maneuverProcedure or surgery

    Also called membrane decollege, membrane sweep

    The Hamilton maneuver is performed by inserting one or two fingers through the internal cervical os and carefully producing a circumferential rotational movement through the uterine segment in order to separate the fetal membranes from the decidua. This maneuver is recommended in order to reduce the need for formal induction.

Study groups in NCT06809985
Study groupRoleWhat they receive
Hamilton maneuverExperimentalThe Hamilton maneuver is performed by inserting one or two fingers through the internal cervical os and carefully producing a circumferential rotational movement through the uterine segment in order to separate the fetal membranes from the decidua. This maneuver is recommended in order to reduce the need for formal induction.
Receives: Procedure: Hamilton maneuver
ControlNo interventionA normal gynecological evaluation will be performed, no additional maneuvers will be performed in addition to the routine evaluation of the patient.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time from admission until active phase

    time from the intervention to reach a cervical dilatation greater than or equal to 5 cm

    Measured: Since intervention until 20 hours

Secondary outcomes (3)
  1. Rate of cesarean births

    number of cesarean sections in the patients

    Measured: Since intervention until 7 days or maternal discharge

  2. Level of Maternal satisfaction

    For the evaluation of the perception of support and birth control, the Mackey MSCRS scale will be used, with a baseline assessment when the patient has cervical dilatation between 0 and 3 cm and a second assessment 24 hours after delivery, there are 35 items, likert scale type, For the evaluation of the perception of support and birth control, the Mackey MSCRS scale will be used, with a baseline assessment when the patient has cervical dilatation between 0 and 3 cm and a second assessment 24 hours after delivery.

    Measured: Since intervention until 24 hours of delivery or maternal discharge

  3. Rate of maternal complications

    Signs of maternal complications as fever, endometritis

    Measured: Since intervention until 14 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Feb 2025
  2. Study start31 Jan 2025
  3. Primary completion31 Jul 2025
  4. Study completion1 Sep 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Single-blind, parallel-group, efficacy, superiority, single-blind clinical trial.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
71 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06809985
Sponsor's protocol ID
PGO-UNAH-48-6-2025
Acronym
DEMEM
Status last verified
Sep 2025
First submitted
15 Jan 2025
Last updated
4 Dec 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: It is not necessary, none of the 18 HIPAA identifiers will be placed

Publications

  • Finucane EM, Murphy DJ, Biesty LM, Gyte GM, Cotter AM, Ryan EM, Boulvain M, Devane D. Membrane sweeping for induction of labour. Cochrane Database Syst Rev. 2020 Feb 27;2(2):CD000451. doi: 10.1002/14651858.CD000451.pub3.

    PubMed 32103497

Questions about this trial

What is this clinical trial studying?

A study testing Hamilton maneuver in people with Cesarean Delivery and Cervical Ripening, run by Ricardo A Gutierrez Ramirez, MD, MSc, FACOG at 1 site in Honduras.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Honduras. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time from admission until active phase (time frame: Since intervention until 20 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06809985, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Dec 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in